Skip to main content
. 2020 Sep 1;12(9):837. doi: 10.3390/pharmaceutics12090837

Table 1.

Features of different types of nanocarriers.

Nanocarrier Type Advantages Challenges/Limitations Safety Concerns References
Liposome
  • Biocompatible

  • Easily modifiable

  • Large drug loading capacity

  • Self-assembly

  • Fast clearance

  • Off-target accumulation

  • Good safety profile

[10,11,12,16,17]
Biodegradable Polymeric Micelle
  • Versatile compositions

  • Biocompatible

  • Self-assembly

  • Prolonged therapeutic efficacy

  • Relatively low drug loading capacity

  • May reduce the effectiveness of the conjugated drug

  • Good safety profile

[23,24,25,26,27]
Carbon Nanotube (CNT)
  • Easily internalized by cells

  • Insoluble unless functionalized

  • Morphology induced toxicity

  • Surface charge-dependent toxicity

[40,41,42,43,44,45,46]
Carbon Dot (CD)
  • High drug loading yield

  • Better controllability in drug conjugation

  • High fluorescent quality

  • Easily internalized by cells

  • Slow drug release

  • May reduce the effectiveness of a conjugated drug

  • Toxicity depends on surface charge

  • PEGylated CDs that are neutrally charged present to be safe

[49,50,51,52,55,56]
Iron Oxide Nanoparticle
  • Potent magnetic and catalytic properties

  • Biocompatibility

  • High drug loading capacity

  • Performance directly related to size, shape, and surface charge

  • Conflicting toxicity evidence

  • ROS generation

[57,58,60,61,62]
Nanogel
  • High biocompatibility

  • High drug loading capacity

  • High water content

  • Tunable size and stability

  • Fast clearance

  • Off-target accumulation

  • Surface charge

  • Difficulties in controlling both degradation and drug release

  • Drug loading and targeting capacity may change when deformity occurs

  • Good safety profile

[63,64,65,66,67]
Dendrimer
  • High surface to volume ratio

  • Capacity to entrap large molecular weight hydrophilic/hydrophobic entities

  • Fast clearance

  • Off-target accumulation

  • Toxicity issues with cationic dendrimers

[68,69,70,72]